Fuse Medical, Inc. Announces Resignation of William E. McLaughlin, III as Chief Financial Officer
December 03, 2021 at 03:17 pm EST
Share
On November 29, 2021, William E. McLaughlin, III resigned as Chief Financial Officer of Fuse Medical, Inc. as well as from all other positions Mr. McLaughlin held with the Company and its subsidiaries. On December 3, 2021, Fuse Medical, Inc. engaged CFO Consulting Partners, LLC to provide interim Chief Financial
Officer (CFO) services, which include oversight and support to the current financial and operational processes
and capabilities of the Company, while also providing organizational assessments and tool development while the
Company searches for a permanent CFO.
Fuse Medical, Inc. is a manufacturer and distributor of medical devices in the United States. The Company provides a range of a portfolio of orthopedic implants, including foot and ankle, orthopedics, sports medicine and spine. It also provides a range of osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. Its foot and ankle product offerings include internal and external fixation for forefoot, midfoot and hindfoot reconstruction. Its orthopedics offer joint reconstruction systems for upper and lower extremities, which include the sterizo total knee, tibial revision, and total hip replacement systems, as well as the arrow total and reverse total shoulder system. Its sports medicine offers a line of fuse suture anchors and interference screws, as well as multiple products for soft tissue fixation augmentation. Its spine offers spinal products for cervical and thoracolumbar fusion.
FUSE MEDICAL, INC. 
